Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.

doi:10.1002/jcp.29388

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.

Journal of cellular physiology - 1 Jun 2020

Seifi Sima, Pouya Farzaneh, Rahmani Mahsa, Mehramiz Mehrane, Rastgar-Moghadam Azam, Gharib Masoumeh, Rahmani Farzad, Shahidsales Soodabeh, Hassanian Seyed Mahdi, Khazaei Majid, Dadjoo Parisa, Parvin Seyede Sara, Yazdinezhad Yeganeh, Parizadeh Seyed Mohammad Reza, Ferns Gordon A, Fathi Mehdi, Avan Amir

Abstract excerpt

There is a growing body of data reporting the association of genetic alterations in chromosome 9P21 with the risk of developing cancer. In the current study, we studied the association of a genetic variant in CDKN2A/B, rs1333049, with the risk of developing breast cancer. A total of 339 participants with and without breast cancer entered to the study. Genotyping was done by the TaqMan real-time polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alleles

Share to Breast Neoplasms

Share to Cyclin B

Share to Cyclin-Dependent Kinase Inhibitor p15

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Gene Expression Regulation, Neoplastic

Share to Risk Factors

Source

Open in PubMed

Identifiers

PMID: 31721206
DOI: 10.1002/jcp.29388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.PMID 31721206Read ↗

A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.Semantic proximity Read ↗

Association between genetic variants at 9p21 locus with risk of breast cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Altered expression and mutations in cell cycle genes CCND1, CDK4, CDKN2B and TP53 are associated with Pakistani breast cancer patientsSemantic proximity Read ↗

Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.Semantic proximity Read ↗

APOBEC3 deletion increases the risk of breast cancer: a meta-analysis.Semantic proximity Read ↗

CCND1 and CDKN1B polymorphisms and risk of breast cancer.Semantic proximity Read ↗

Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer.Semantic proximity Read ↗

Coffee Intake Interacted with the Bcl-2 rs1944420, rs7236090, and rs2849382 Haplotype to Influence Breast Cancer Risk in Middle-Aged Women.Semantic proximity Read ↗

Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis.Semantic proximity Read ↗

Altered expression and mutations in cell cycle genes CCND1, CDK4, CDKN2B and TP53 are associated with Pakistani breast cancer patients.Semantic proximity Read ↗

BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility.Semantic proximity Read ↗

Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.